{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:42:28Z","timestamp":1791294148268,"version":"4.1.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monoclonal antibodies represent a promising approach to fight a variety of tumors, but their mode of action remains to be fully understood. NK cells can recognize Ab-coated targets, as well as stress ligands, on tumor cells. In this study, we investigated how NK cells integrate both kinds of activating signals. NK cell\u2013mediated killing was maximal with the combined recognition of NKG2D ligands and Ab; surprisingly, only NKG2D engagement substantially enhanced degranulation. Conversely, Ab recognition by NK cells uniquely increased contact stability with tumor cells. Furthermore, using intravital imaging of solid tumors, we showed that Ab recognition favored prolonged interactions between NK cells and targets. Altogether, our results demonstrate that NK cell\u2013mediated killing can be differentially regulated at the level of degranulation and contact stability by distinct activating receptors. Thus, complementary signals mediated by recognition of stress ligands and tumor-specific Abs may contribute to the efficacy of NK cells during mAb therapy.<\/jats:p>","DOI":"10.4049\/jimmunol.1202065","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T01:54:36Z","timestamp":1353981276000},"page":"5493-5497","source":"Crossref","is-referenced-by-count":44,"title":["Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell\u2013Tumor Cell Interactions"],"prefix":"10.1093","volume":"189","author":[{"given":"Jacques","family":"Deguine","sequence":"first","affiliation":[{"name":"Dynamics of Immune Responses Unit, Institut Pasteur, 75015 Paris, France; and INSERM U668 , 75015 Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Breart","sequence":"additional","affiliation":[{"name":"Dynamics of Immune Responses Unit, Institut Pasteur, 75015 Paris, France; and INSERM U668 , 75015 Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Lema\u00eetre","sequence":"additional","affiliation":[{"name":"Dynamics of Immune Responses Unit, Institut Pasteur, 75015 Paris, France; and INSERM U668 , 75015 Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bousso","sequence":"additional","affiliation":[{"name":"Dynamics of Immune Responses Unit, Institut Pasteur, 75015 Paris, France; and INSERM U668 , 75015 Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,12,15]]},"reference":[{"key":"2025032409394155700_r1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"2025032409394155700_r2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"2025032409394155700_r3","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1200\/JCO.2009.27.6360","article-title":"Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape","volume":"28","author":"Ferris","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"2025032409394155700_r4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025032409394155700_r5","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1158\/1078-0432.CCR-1087-3","article-title":"Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin\u2019s lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response","volume":"10","author":"Gluck","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"2025032409394155700_r6","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-06-1860","article-title":"Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab","volume":"13","author":"Berdeja","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"2025032409394155700_r7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"2025032409394155700_r8","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1073\/pnas.201238598","article-title":"Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo","volume":"98","author":"Cerwenka","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409394155700_r9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"key":"2025032409394155700_r10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","article-title":"NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy","volume":"28","author":"Guerra","year":"2008","journal-title":"Immunity"},{"key":"2025032409394155700_r11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.20050240","article-title":"Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection","volume":"202","author":"Routes","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025032409394155700_r12","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"2025032409394155700_r13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2005-04-1351","article-title":"Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion","volume":"107","author":"Bryceson","year":"2006","journal-title":"Blood"},{"key":"2025032409394155700_r14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2010.09.016","article-title":"Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression","volume":"33","author":"Deguine","year":"2010","journal-title":"Immunity"},{"key":"2025032409394155700_r15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI34388","article-title":"Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice","volume":"118","author":"Breart","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2025032409394155700_r16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ni1322","article-title":"Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1","volume":"7","author":"Gazit","year":"2006","journal-title":"Nat. Immunol."},{"key":"2025032409394155700_r17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/eji.1830270206","article-title":"Synergy between an antibody and CD8+ cells in eliminating an established tumor","volume":"27","author":"Vasovic","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"2025032409394155700_r18","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1182\/blood-2009-06-225359","article-title":"Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity","volume":"114","author":"Wood","year":"2009","journal-title":"Blood"},{"key":"2025032409394155700_r19","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.febslet.2009.03.014","article-title":"Intercellular exchange of proteins: the immune cell habit of sharing","volume":"583","author":"Rechavi","year":"2009","journal-title":"FEBS Letters"},{"key":"2025032409394155700_r20","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1111\/j.1582-4934.2008.00586.x","article-title":"Visualizing CTL\/melanoma cell interactions: multiple hits must be delivered for tumor cell annihilation","volume":"13","author":"Caramalho","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"2025032409394155700_r21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijc.24351","article-title":"Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC","volume":"125","author":"Inagaki","year":"2009","journal-title":"Int. J. Cancer"},{"key":"2025032409394155700_r22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/leu.2011.288","article-title":"Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity","volume":"26","author":"Kellner","year":"2011","journal-title":"Leukemia"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/189\/12\/5493\/61754974\/1202065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/189\/12\/5493\/61754974\/1202065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T02:18:14Z","timestamp":1743041894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/189\/12\/5493\/7999026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1202065","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717970461.793469057","asserted-by":"object"}]},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,12]]},"published":{"date-parts":[[2012,12]]}}}